ABCF2

Prothrombin UniProt accession P00734

Thrombin, which cleaves bonds after Arg and Lys, converts fibrinogen to fibrin and activates factors V, VII, VIII, XIII, and, in complex with thrombomodulin, protein C. Functions in blood homeostasis, inflammation and wound healing. Activates coagulation factor XI (F11); activation is promoted by the contact with negatively charged surfaces (PubMed:2019570, PubMed:21976677).

Triggers the production of pro-inflammatory cytokines, such as MCP-1/CCL2 and IL8/CXCL8, in endothelial cells (PubMed:30568593, PubMed:9780208)

Source: UniProt

Heterodimer (named alpha-thrombin) of a light and a heavy chain; disulfide-linked. Forms a heterodimer with SERPINA5. In plasma, interacts (via N-terminus) with alpha-1-microglobulin with molar ratio 1:2 and 1:1; this interaction does not prevent the activation of prothrombin to thrombin.

Interacts (thrombin) with iripin-8, a serine protease inhibitor from Ixodes ricinus saliva (PubMed:34502392). Interacts (thrombin) with iripin-3, a serine protease inhibitor from Ixodes ricinus saliva (PubMed:33732248). Interacts (thrombin) with Anopheles albimanus salivary thrombin inhibitor anophelin; the interaction results in thrombin inhibition (PubMed:23223529).

Interacts (thrombin) with Anopheles gambiae salivary thrombin inhibitor anophelin; the interaction results in thrombin inhibition (PubMed:28592490). Interacts (thrombin) with Amblyomma variegatum variegin; the interaction results in thrombin inhibition (PubMed:22053189). Interacts (thrombin) with Xenopsylla cheopis salivary thrombin inhibitor XC-42 (PubMed:34688666).

Interacts (thrombin) with Xenopsylla cheopis salivary thrombin inhibitor XC-43 (PubMed:34688666)

Source: UniProt
Secreted, extracellular space
Source: UniProt

Expressed by the liver and secreted in plasma

Source: UniProt
  • Factor II deficiency (FA2D)

    A very rare blood coagulation disorder characterized by mucocutaneous bleeding symptoms. The severity of the bleeding manifestations correlates with blood factor II levels.

  • Ischemic stroke (ISCHSTR)

    A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.

  • Thrombophilia due to thrombin defect (THPH1)

    A multifactorial disorder of hemostasis characterized by abnormal platelet aggregation in response to various agents and recurrent thrombi formation.

  • Pregnancy loss, recurrent, 2 (RPRGL2)

    A common complication of pregnancy, resulting in spontaneous abortion before the fetus has reached viability. The term includes all miscarriages from the time of conception until 24 weeks of gestation. Recurrent pregnancy loss is defined as 3 or more consecutive spontaneous abortions.

Source: UniProt
  • Intrinsic Pathway of Fibrin Clot Formation
  • Common Pathway of Fibrin Clot Formation
  • Gamma-carboxylation of protein precursors
  • Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus
  • Removal of aminoterminal propeptides from gamma-carboxylated proteins
  • Cell surface interactions at the vascular wall
  • Peptide ligand-binding receptors
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Platelet Aggregation (Plug Formation)
  • Defective factor XII causes hereditary angioedema
  • Defective F8 cleavage by thrombin
  • Regulation of Complement cascade
Source: Reactome via UniProt

Mutations

No mutation information available.

Synthetic Lethal Network

Genes with an experimentally identified or computationally predicted synthetic-lethal relationship to ABCF2, aggregated across our SSL data sources. Click any partner node to view that gene’s page.

Nodes and edges are coloured by the SSL data source. Partners appearing in more than one source are shown in grey.

BioGRID SLOrth SynLethDB MexDrugs Multi-source
Sources: BioGRID, SLOrth, SynLethDB, MexDrugs

Clinical Trials

Total Trials Found: 15

NCT ID Condition Brief Title Phase Status
NCT06689839 Aortic Stenosis Treated With TAVI, Aortic Diseases Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR NA RECRUITING
NCT04069338 Kidney Stone, Kidney Calculi, Ureteral Calculi, Ureterolithiasis, Urolithiasis Comparison of Lithotripsy Urolithiasis Machines NA COMPLETED
NCT01250223 Lymphoma, Follicular Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study) N/A COMPLETED
NCT05893082 Aortic Stenosis Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR NA COMPLETED
NCT00913159 Urolithiasis A Trial Comparing Efficacy of HM3 Versus F2 Lithotripters for Stone Fragmentation NA TERMINATED
NCT06069661 Aortic Stenosis U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR NA WITHDRAWN
NCT05147090 Chronic Hepatitis b, NAFLD, Cirrhosis, Fibrosis, Liver, Empagliflozin, SGLT2 Inhibitors Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients PHASE4 ACTIVE_NOT_RECRUITING
NCT03183570 Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, Covid19 Pneumonia Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT EARLY_PHASE1 COMPLETED
NCT05637034 Tumor, Solid 68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer NA UNKNOWN
NCT06632444 Metabolic Dysfunction Associated Steatohepatitis (MASH), Liver Fibrosis LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis PHASE3 RECRUITING